Fulgent Genetics Soars: Earnings Beat Sparks Significant Stock Surge
Fulgent Genetics Inc. (NASDAQ: FLGT) recently experienced a significant upward movement in its stock price, gapping up notably following an earnings announcement that surpassed market expectations. This…
William Blair Boosts Repligen’s FY2025 EPS Estimates: What Investors Need to Know
William Blair, a prominent financial analysis firm, recently revised its earnings per share (EPS) estimates for Repligen Corporation, a leading biotechnology company listed on NASDAQ under the…
Wall Street Analysts Reveal Top 10 Biotech Stocks Poised for Breakout
The biotechnology sector, long a challenging arena for investors, is now showing significant signs of a potential breakout, according to leading Wall Street analysts. This shift in…